05/08/2026
๐๐๐ฅ ๐๐ซ๐ฃ๐๐ก๐๐ฆ ๐๐๐ฆ๐ง ๐ข๐ ๐ฉ๐๐ง-๐๐ซ๐๐ ๐ฃ๐ง ๐ ๐๐๐๐๐๐ก๐๐ฆ ๐ง๐ข ๐๐๐ฆ๐ ๐๐๐๐๐ง๐๐๐๐ฅ๐ ๐๐ข๐ฆ๐ง๐ฆ ๐๐ข๐ฅ ๐๐๐๐๐ฃ๐๐ก๐ข๐ฆ
As part of the governmentโs continuing efforts to make healthcare more accessible and affordable, the Bureau of Internal Revenue (BIR) has issued Revenue Memorandum Circular (RMC) No. 87-2026, publishing the updated list of Value-Added Tax (VAT)-exempt medicines endorsed by the Food and Drug Administration (FDA) pursuant to Republic Act No. 10963 (TRAIN Law) and Republic Act No. 11534 (CREATE Act).
The issuance supports President Ferdinand R. Marcos Jr.โs directive during his 2026 State of the Nation Address (SONA) to expand access to quality healthcare by reducing the cost of essential medicines.
BIR Commissioner Charlito Martin R. Mendoza emphasized the Bureauโs commitment to implementing tax policies that directly improve the lives of Filipinos.
โThe Bureau remains steadfast in implementing tax policies that directly benefit our people. By expanding the list of VAT-exempt medicines, we are helping make essential healthcare more affordable while supporting the Presidentโs vision of a healthier and more resilient Philippines,โ Commissioner Mendoza said.
With the latest update, the number of VAT-exempt medicines has increased to 2,277, including 14 newly added medicines. The expanded coverage helps reduce out-of-pocket medical expenses, particularly for Filipinos undergoing long-term treatment for chronic and life-threatening illnesses.
The updated list now covers medicines used in the treatment of:
* Cancer โ 708 medicines
* Hypertension โ 537 medicines
* Diabetes โ 331 medicines
* Mental Illness โ 300 medicines
* High Cholesterol โ 172 medicines
* Kidney Disease โ 152 medicines
* Tuberculosis โ 77 medicines
Every peso saved through the VAT exemption helps families continue treatment, purchase essential medicines, and better manage their daily needs.
By making healthcare more affordable, the government also supports better treatment outcomes and improves the quality of life of millions of Filipinos.
While the Bureau continues to fulfill its mandate of generating revenues for national development, it likewise ensures that the tax system delivers meaningful and tangible benefits to the Filipino people.
For more information, you may access:
Revenue Memorandum Circular No. 87-2026
https://bir-cdn.bir.gov.ph/BIR/pdf/RMC%20No.%2087-2026_redacted.pdf
Updated Full List of VAT-Exempt Medicines (Annex A)
https://bir-cdn.bir.gov.ph/BIR/pdf/RMC%2087-2026%20Annex%20A%20(6).pdf
